Josep Solà is the Co-Founder and Chief Technology Officer of Aktiia, a pioneer in continuous, cuffless blood pressure monitoring. With a PhD in biomedical signal processing and over two decades of research experience, Josep has dedicated his career to making cardiovascular health more accessible through innovation. 

At Aktiia, he leads the technical vision to deliver 24/7 blood pressure insights with medical-grade accuracy, without the burden of traditional cuffs. His belief that "everyone deserves a healthy blood pressure if great technology is made available" drives Aktiia’s mission to radically improve the way hypertension — the world's leading chronic condition — is diagnosed, monitored, and managed. 

Aktiia, under his leadership, launched in 2022 the first clinically validated wearable for continuous blood pressure tracking in daily life. Now trading as Hilo, the company is also rolling out the world’s first smartphone application capable of measuring blood pressure using only the camera of any smartphone, with no external devices and no calibration needed. This breakthrough will remove barriers to blood pressure monitoring globally, making it accessible to billions and representing a game-changing shift in preventive healthcare and early detection of hypertension.